The latest stocks of this drug should be exhausted by March.
MO12345lemonde with AFP
Used against various infectious diseases, the Josacine antibiotic will soon leave the stalls of the pharmacies, because its only manufacturer in arrest production, the health authorities announced on Monday, February 27, in a context already marked by the shortage of multiple treatments .
The Astellas laboratory “has decided to stop the marketing of all the presentations of the Josacine specialty,” said in a press release The National Medicines Safety Agency (ANSM).
Josacine is the trade name of josamycine, an antibiotic, which is used against various infectious diseases hitting the lungs, the throat, the sinuses … Now “no other specialty based on josamycine is available in France”, Prevents the ANSM, while the last stocks should run out in March. 2>
stocks quickly exhausted
This judgment is the fruit of a choice of the manufacturer, which motivated it by an “industrial decision”, without more precision. The safety and efficiency of the drug are not involved. The group had planned a plan to allow the presence for several more years of josacin in the stalls. But, in the current context of shortage of antibiotics, stocks have been emptied much more than expected, it is said on the ANSM website.
Doctors and pharmacists can however turn to recent recommendations from the main infectiology companies, which have evaluated how to best replace josacin with treatments from the same family.
This medication is also linked in the spirits to the case of “poisoned josacin”, linked to the death of a child, which was attributed to the poisoning of the cyanide of a bottle of This antibiotic. But the safety of treatment itself has never been disputed.